HEMATEIN manufacturers
- Hematein
-
- $1.00 / 1KG
-
2025-12-12
- CAS:475-25-2
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 100000KG
|
| | HEMATEIN Basic information |
| Product Name: | HEMATEIN | | Synonyms: | 3,4,6a,10-tetrahydroxy-6,7-dihydroindeno[2,1-c][1]benzopyran-9-one;TIMTEC-BB SBB006464;HEMATEIN FOR MICROSCOPY;LABOTEST-BB LT00441274;HYDROXYBRASILEIN;HEMATEIN;HAEMATEIN;2-d)pyran-9(6h)-one,6a,7-dihydro-3,4,6a,10-tetrahydroxy-benz(b)indeno( | | CAS: | 475-25-2 | | MF: | C16H12O6 | | MW: | 300.26 | | EINECS: | 207-492-8 | | Product Categories: | G-H-I;Stains and Dyes;Stains&Dyes, A to | | Mol File: | 475-25-2.mol |  |
| | HEMATEIN Chemical Properties |
| Melting point | 180 °C | | Boiling point | 361.5°C (rough estimate) | | density | 1.2766 (rough estimate) | | refractive index | 1.4600 (estimate) | | storage temp. | 2-8°C | | solubility | Methanol (Slightly) | | pka | 8.02±0.40(Predicted) | | form | Crystalline Powder | | Colour Index | 75290 | | color | Dark brown | | Water Solubility | 0.6g/L(20 ºC) | | Merck | 13,4651 | | BRN | 93039 | | LogP | 0.560 (est) | | EPA Substance Registry System | Benz[b]indeno[1,2-d]pyran-9(6H)-one, 6a,7-dihydro-3,4,6a,10-tetrahydroxy- (475-25-2) |
| Safety Statements | 24/25 | | WGK Germany | 3 | | RTECS | DE3120000 | | F | 8-10-23 | | TSCA | TSCA listed | | HS Code | 32030010 |
| | HEMATEIN Usage And Synthesis |
| Chemical Properties | dark brown crystalline powder | | Uses | CK2 inhibitor, antineoplastic, TNFa inhibitor, antiinflammatory | | Uses | As an indicator like hematoxylin; for staining animal tissue, particularly cell nuclei. | | Uses | Hematein is a stain for the cell nuclei of animal tissue. Also suggested to possess use as a stain for myelin sheaths and nerve fibers. An oxidized version of hematoxylin. Color index: 75290. Dyes and metabolites. | | Definition | ChEBI: An organic heterotetracyclic compound that is -6a,7-dihydrobenzo[b]indeno[1,2-d]pyran-9-one carrying four hydroxy substituents at positions 3, 4, 6a and 10. | | in vivo | Hematein (intraperitoneal injections; 50 mg/kg; twice a week for 6 weeks) inhibits tumor growth in A427 lung cancer cell xenografts[1].
| Animal Model: | Female athymic BALB/c nude mice (6-week-old) [1] | | Dosage: | 50 mg/kg | | Administration: | Intraperitoneal injections; twice a week for 6 weeks | | Result: | Inhibited tumor growth in A427 lung cancer cell xenografts.
|
| | IC 50 | CKII: 0.74 μM (IC50) |
| | HEMATEIN Preparation Products And Raw materials |
|